Skip to content

Our aims

The key objectives of the initiative EB-CLINET are to improve medical care for people with EB by encouraging the collaboration between health care professionals working with EB and to accelerate the way to a cure for this disease by supporting the exchange of knowledge and the latest developments in EB research and EB care.

Our aims are:


  • to provide Information about trainings, meetings and EB-related events, on recent developments regarding treatments and research and updates on clinical trials, or calls for recruitment of collaborators. Sign up to our newsletter!

Collaboration & Connection

  • to strengthen the collaboration between health care professionals and institutions worldwide already providing specialized medical care for people with EB.
  • to find contacts for medical care in the field of EB in and outside Europe presently lacking any such service - include these clinical contacts in the network and build up EB relevant knowledge there.
  • to set up an online database of EB centres accessible to medical specialists as well as patients. See the partner map

International cooperation is a vital prerequisite for the exchange of knowledge and experiences in order to provide comprehensive coverage of medical care for EB patients all over the world.



  • to train and instruct medical specialists so that they can act as EB specialists in their national EB centres. See events & trainings

Awareness/Role Model

  • to increase awareness and knowledge about EB and rare diseases
  • to establish a role model for other rare diseases on how a network could be build and operated to share experiences and improve the quality of life of patients

„With EB-CLINET we wish to provide a platform for connection, communication and collaboration.”

Dr. Sophie Kitzmueller, Head of EB-CLINET
Back to main navigation
This website uses cookies to give you the best possible service. By using this website, you agree to the use of cookies. Detailed information can be found in our privacy policy .